019170.KO Shin Poong Pharm.Co.Ltd.

Healthcare Pharmaceuticals Korea Stock Exchange
8,537 KRW
Close of Nov 5, 2026
6,310 15,680
Market cap
KRW 441B
P/E
-
P/B
1.63x
ROE
-5.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 019170.KO undervalued?

Graham number

The Graham number of Shin Poong Pharm.Co.Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shin Poong Pharm.Co.Ltd. fundamental analysis

No fundamental analysis for Shin Poong Pharm.Co.Ltd. yet.

Shin Poong Pharm.Co.Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shin Poong Pharm.Co.Ltd.

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder…

Full company profile